Increased levels of TKT, NAMPT, IDH2, LAT1, NDUFA3, and CYP4F11 proteins indicate that restored DIO1 expression further boosts pro-tumorous metabolic changes in ccRCC cells. This evidence concerns the gene IDH2 and nonpapillary renal cell carcinoma.